Flagship Harbor Advisors’s Nuvation Bio NUVB Stock Holding History
Bought
Maintained
Sold
Other funds holding NUVB
DC
VCM
OFM
LCM
DFO
Flagship Harbor Advisors's NUVB Position: Q1 2026 in Review
Flagship Harbor Advisors sold out of Nuvation Bio (NUVB) in Q1 2026, closing a stake of 2,500 shares — an estimated $22.4K sold.
Flagship Harbor Advisors first reported a position in NUVB in Q4 2025 and held it in 1 quarter. The position peaked at $22.4K in Q4 2025. 231 funds tracked by Wall St. Rank hold NUVB as of Q1 2026.
- Flagship Harbor Advisors reported no remaining Nuvation Bio position as of Q1 2026 after selling out during the quarter.
- Flagship Harbor Advisors sold 2,500 Nuvation Bio shares in Q1 2026, an estimated $22.4K.
- Flagship Harbor Advisors first reported a position in Nuvation Bio in Q4 2025 and held it in 1 quarter.
- Flagship Harbor Advisors's Nuvation Bio position peaked at $22.4K in Q4 2025.
- 231 funds tracked by Wall St. Rank held Nuvation Bio as of Q1 2026.
Based on Flagship Harbor Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.